Product Information

TEMAZEPAM 15 MG CAPSULE is a generic product labeled by SpecGx LLC, priced at $0.0791 per EA under NDC 00406996101. Its NADAC has been published 324 times since Jun 10, 2020.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the temazepam market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TEMAZEPAM 15 MG CAPSULE

temazepam
$0.0791per EA
High Outlier
DEA Schedule CIV

Strength

15 mg/1

Manufacturer

SpecGx LLC

NDC

00406996101

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TEMAZEPAM

Approval Type

New Drug (NDA)

FDA Application

NDA018163

FDA Approved

Before 1982

TE Code

AB

On Market Since

2/23/2010

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for TEMAZEPAM 15 MG CAPSULE has been published 324 times since Jun 10, 2020, and over the history we have for it it has risen 6.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0791 per EA
All-time high$0.0822 (May 11, 2022)
All-time low$0.0548 (Nov 20, 2024)
52-week high$0.0793
52-week low$0.0756
Median price$0.0772
Average price$0.0753
Largest weekly change-29.8% (Nov 20, 2024)
Weeks tracked324
Tracking sinceJun 10, 2020

Price History

1W

-0.3%

1M

-0.3%

3M

-0.2%

6M

+1.5%

1Y

+2.8%

3Y

+4.8%

5Y

-2.6%

All

+6.3%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TEMAZEPAM 15 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 15 MG CAPSULE, manufactured by SpecGx LLC, is $0.0791 per EA (NDC 00406996101), effective Aug 19, 2026.

How has the price of TEMAZEPAM 15 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TEMAZEPAM 15 MG CAPSULE has risen 6.3%. It has been tracked across 324 weekly CMS publications since Jun 10, 2020.

What are the highest and lowest recorded NADAC prices for TEMAZEPAM 15 MG CAPSULE?

Since Jun 10, 2020, the NADAC for TEMAZEPAM 15 MG CAPSULE has ranged from a low of $0.0548 (Nov 20, 2024) to a high of $0.0822 (May 11, 2022), with a median of $0.0772 per EA.

Are there cheaper alternatives to TEMAZEPAM 15 MG CAPSULE?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TEMAZEPAM 15 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TEMAZEPAM 15 MG CAPSULE?

TEMAZEPAM 15 MG CAPSULE (NDC 00406996101) is labeled by SpecGx LLC, and CMS classifies it as a generic product.